Drugs / Purified inactivated influenza virus antigen
last change May 2019 re-read 3 minutes ago

Purified inactivated influenza virus antigen

Vaccine

Developed for
influenza
Investigated by
Green Cross Corporation · Seoul National University Hospital

Trials 1

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT03590808 Sep → Dec 2018 carcinoma, influenza Seoul National University Hospital Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Purified inactivated influenza virus antigen “Purified inactivated influenza virus antigen (Green Cross Corp) 0.5 mL once IM” NCT03590808 ↗
Modality Vaccine “influenza vaccine” NCT03590808 ↗
Route Intramuscular “0.5 mL once IM” NCT03590808 ↗